Mizuho Securities Maintains Nevro(NVRO.US) With Hold Rating, Cuts Target Price to $8
RBC Capital Maintains Nevro(NVRO.US) With Hold Rating, Maintains Target Price $7
Nevro Is Maintained at Neutral by Citigroup
Nevro Analyst Ratings
Citi Maintains Nevro(NVRO.US) With Hold Rating, Cuts Target Price to $6
Nevro Corp: Underperform Rating With Reduced Price Objective Amid Revenue Decline and Market Challenges
RBC Capital Maintains Nevro(NVRO.US) With Hold Rating, Cuts Target Price to $7
RBC Capital Keeps Their Hold Rating on Nevro Corp (NVRO)
J.P. Morgan Maintains Nevro(NVRO.US) With Sell Rating
J.P. Morgan Downgrades Nevro Corp (NVRO) to a Sell
Nevro Analyst Ratings
Nevro Price Target Announced at $6.89/Share by Citigroup
Hold Rating on Nevro Corp Amid Reduced Revenue Forecast and Market Uncertainty
Truist Securities Maintains Hold on Nevro, Lowers Price Target to $5.5
Nevro Price Target Cut to $7.00/Share From $16.00 by RBC Capital
Hold Rating Maintained Amidst Nevro Corp's Declining Revenues and Market Challenges
Piper Sandler Remains a Sell on Nevro Corp (NVRO)
RBC Capital Reaffirms Their Hold Rating on Nevro Corp (NVRO)
Nevro Analyst Ratings
Piper Sandler Maintains Underweight on Nevro, Lowers Price Target to $7